Monday, May 25, 2009

They May be “On Therapy”, But They Are Not Taking Their Meds…

An interesting presentation by Eli Lilly and Company at the 8th European Congress on Menopause trumpeted recent study results showing that the majority of patients tested stayed on EVISTA for the first two years (96.4%, 80.5% and 62% of patients persisted at 12, 24, and 36 months respectively). What seems a little strange, however, is that the mean MPR was only 52.8%. Apparently, only 38.5% of patients were actually adherent (MPR <80%).